Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Human immunodeficiency virus type 1 nucleocapsid inhibitors impede trans infection in cellular and explant models and protect nonhuman primates from infection.

Wallace GS, Cheng-Mayer C, Schito ML, Fletcher P, Miller Jenkins LM, Hayashi R, Neurath AR, Appella E, Shattock RJ.

J Virol. 2009 Sep;83(18):9175-82. doi: 10.1128/JVI.00820-09. Epub 2009 Jul 8.

2.

Development of a gel permeation chromatographic assay to achieve mass balance in cellulose acetate phthalate stability studies.

Mayhew JW, Gideon LT, Ericksen B, Hlavaty JJ, Yeh SM, Chavdarian CG, Strick N, Neurath AR.

J Pharm Biomed Anal. 2009 Feb 20;49(2):240-6. doi: 10.1016/j.jpba.2008.10.039. Epub 2008 Nov 5.

3.

Cellulose sulfate for prevention of HIV infection.

Neurath AR.

N Engl J Med. 2008 Nov 6;359(19):2066-7; author reply 2067-8. doi: 10.1056/NEJMc081834. No abstract available.

PMID:
18987376
4.

Anti-HIV-1 activity of poly(mandelic acid) derivatives.

Ward M, Yu B, Wyatt V, Griffith J, Craft T, Neurath AR, Strick N, Li YY, Wertz DL, Pojman JA, Lowe AB.

Biomacromolecules. 2007 Nov;8(11):3308-16. Epub 2007 Oct 20.

PMID:
17949101
5.

Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides.

Neurath AR, Strick N, Li YY.

BMC Infect Dis. 2006 Oct 16;6:150.

6.

Cellulose acetate 1,2-benzenedicarboxylate inhibits infection by cell-free and cell-associated primary HIV-1 isolates.

Lu H, Zhao Q, Wallace G, Liu S, He Y, Shattock R, Neurath AR, Jiang BS.

AIDS Res Hum Retroviruses. 2006 May;22(5):411-8.

7.

Punica granatum (pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide.

Neurath AR, Strick N, Li YY, Debnath AK.

Ann N Y Acad Sci. 2005 Nov;1056:311-27. Review.

PMID:
16387698
8.

Safety and distribution of cellulose acetate 1,2-benzenedicarboxylate (CAP), a candidate anti-HIV microbicide in rhesus macaques.

Ratterree M, Gettie A, Williams V, Malenbaum S, Neurath AR, Cheng-Mayer C, Blanchard J.

AIDS. 2005 Oct 14;19(15):1595-9.

PMID:
16184028
9.

Cellulose acetate 1,2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus.

Boadi T, Schneider E, Chung S, Tsai L, Gettie A, Ratterree M, Blanchard J, Neurath AR, Cheng-Mayer C.

AIDS. 2005 Oct 14;19(15):1587-94.

PMID:
16184027
11.

Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation.

Fichorova RN, Zhou F, Ratnam V, Atanassova V, Jiang S, Strick N, Neurath AR.

Antimicrob Agents Chemother. 2005 Jan;49(1):323-35.

12.
13.

Water dispersible microbicidal cellulose acetate phthalate film.

Neurath AR, Strick N, Li YY.

BMC Infect Dis. 2003 Nov 14;3:27.

14.

Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides.

Neurath AR, Strick N, Li YY.

BMC Infect Dis. 2002 Nov 21;2:27. Epub 2002 Nov 21.

15.
16.
18.

Quantitation of cellulose acetate phthalate in biological fluids as a complex with ruthenium red.

Neurath AR, Strick N.

Anal Biochem. 2001 Jan 1;288(1):102-4. No abstract available.

PMID:
11141313
19.

Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants.

Kawamura T, Cohen SS, Borris DL, Aquilino EA, Glushakova S, Margolis LB, Orenstein JM, Offord RE, Neurath AR, Blauvelt A.

J Exp Med. 2000 Nov 20;192(10):1491-500.

20.

Effect of a cellulose acetate phthalate topical cream on vaginal transmission of simian immunodeficiency virus in rhesus monkeys.

Manson KH, Wyand MS, Miller C, Neurath AR.

Antimicrob Agents Chemother. 2000 Nov;44(11):3199-202.

21.

Microbicide for prevention of sexually transmitted diseases using a pharmaceutical excipient.

Neurath AR.

AIDS Patient Care STDS. 2000 Apr;14(4):215-9. Review.

PMID:
10806641
22.

In vitro activity of a cellulose acetate phthalate topical cream against organisms associated with bacterial vaginosis.

Neurath AR, Li YY, Mandeville R, Richard L.

J Antimicrob Chemother. 2000 May;45(5):713-4. No abstract available.

PMID:
10797102
23.
24.

Kinetics of interaction between 3-hydroxyphthaloyl-beta-lactoglobulin and CD4 molecules.

Zeder-Lutz G, Neurath AR, Van Regenmortel MH.

Biologicals. 1999 Mar;27(1):29-34.

PMID:
10441400
25.

Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients.

Neurath AR, Strick N, Li YY, Lin K, Jiang S.

Biologicals. 1999 Mar;27(1):11-21.

PMID:
10441398
26.

Effect of 3-hydroxyphthaloyl-beta-lactoglobulin on vaginal transmission of simian immunodeficiency virus in rhesus monkeys.

Wyand MS, Manson KH, Miller CJ, Neurath AR.

Antimicrob Agents Chemother. 1999 Apr;43(4):978-80.

27.

3-Hydroxyphthaloyl beta-lactoglobulin. IV Antiviral activity in the mouse model of genital herpesvirus infection.

Kokuba H, Aurelian L, Neurath AR.

Antivir Chem Chemother. 1998 Jul;9(4):353-7.

PMID:
9875414
28.

3-Hydroxyphthaloyl beta-lactoglobulin. III. Antiviral activity against herpesviruses.

Neurath AR, Strick N, Li YY.

Antivir Chem Chemother. 1998 Mar;9(2):177-84.

PMID:
9875389
29.

Glycodelins GdA and GdS modified by 3-hydroxyphthalic anhydride inhibit gp120-CD4 binding and HIV-1 infection in vitro.

Seppälä M, Jiang S, Strick N, Lin K, Li YY, Koistinen H, Koistinen R, Neurath AR.

Lab Invest. 1997 Aug;77(2):127-30.

PMID:
9274854
30.

Chemically modified bovine beta-lactoglobulin blocks uptake of HIV-1 by colon- and cervix-derived epithelial cell lines.

Jiang S, Lin K, Strick N, Li YY, Neurath AR.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 15;13(5):461-2. No abstract available.

PMID:
8970474
31.

A herpesvirus inhibitor from bovine whey.

Neurath AR, Li YY, Strick N, Jiang S.

Lancet. 1996 Jun 15;347(9016):1703-4. No abstract available.

PMID:
8643002
32.

Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV.

Neurath AR, Jiang S, Strick N, Lin K, Li YY, Debnath AK.

Nat Med. 1996 Feb;2(2):230-4.

PMID:
8574970
34.
35.

Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions.

Neurath AR, Strick N, Lin K, Jiang S.

AIDS Res Hum Retroviruses. 1995 Jun;11(6):687-96.

PMID:
7576928
36.
38.

Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1.

Debnath AK, Jiang S, Strick N, Lin K, Haberfield P, Neurath AR.

J Med Chem. 1994 Apr 15;37(8):1099-108. Erratum in: J Med Chem 1994 Jun 10;37(12):1898.

PMID:
8164251
39.

Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.

Neurath AR, Strick N, Li YY, Jiang S.

AIDS Res Hum Retroviruses. 1993 Dec;9(12):1195-208.

PMID:
8142138
40.

Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41.

Jiang S, Lin K, Strick N, Neurath AR.

Biochem Biophys Res Commun. 1993 Sep 15;195(2):533-8.

PMID:
8373393
41.

HIV-1 inhibition by a peptide.

Jiang S, Lin K, Strick N, Neurath AR.

Nature. 1993 Sep 9;365(6442):113. No abstract available.

PMID:
8371754
42.

B cell antigenic site mapping of HIV-1 glycoproteins.

Neurath AR.

Chem Immunol. 1993;56:34-60. Review. No abstract available.

PMID:
8452653
43.
44.
46.
47.
48.

Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41.

Jiang SB, Lin K, Neurath AR.

J Exp Med. 1991 Dec 1;174(6):1557-63. Erratum in: J Exp Med 1992 Feb 1;175(2):621.

49.

Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full-length V3 hypervariable loops of HIV-1 envelope glycoproteins.

Neurath AR, Jiang S, Strick N, Kolbe H, Kieny MP, Muchmore E, Girard M.

AIDS Res Hum Retroviruses. 1991 Oct;7(10):813-23.

PMID:
1720628

Supplemental Content

Loading ...
Support Center